Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio, including ...

Sun Pharma is set to acquire Checkpoint Therapeutics for $355 million, enhancing its specialty portfolio with UNLOXCYT, an FDA-approved treatment for advanced skin cancer. This acquisition aims to ...

Sun Pharma (Sun) is acquiring US-based early-stage oncology-focused biotech company Checkpoint Therapeutics (Checkpoint) for an upfront cash payment of USD 4.1/share (total outgo of USD 355mn) and ...

Sun Pharma’s market capitalisation is Rs 3.86 lakh crore and the shares are flat compared to the last one year, and down 15% so far in 2025. Advisory Alert: It has come to our attention that ...

As per IIM Bangalore, Management Consulting remained the top career choice followed by Technology/Product Management and ...

With this approval, the company is set to redefine mosquito control strategies in India, offering a powerful, safe, and sustainable approach to tackling vector-borne diseases, as per the company's ...

Sun Pharmaceutical Industries Ltd. on Monday announced it will acquire US-based cancer treatment provider Checkpoint Therapeutics, Inc. for up to $355 million or Rs 3,084 crore. Checkpoint is a ...

Choose from Happy Sun Vector stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

As a registered trust under the Indian Trusts Act of 1882, Aditya Birla Sun Life Mutual Fund is principally ... A minimum investment of Rs. 250 would be required to enrol in a Systematic ...

The company’s order book stood at Rs 816.91 crore as of December 2024. The stock's sharp decline comes despite Zen Technologies' announcement of strategic investments in Vector Technics and Bhairav ...